Clinical Trial Update: Arachidonic Acid Supplementation in Very Preterm Infants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating arachidonic acid supplementation in very preterm infants has completed, assessing its impact on impaired psychomotor develop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Psychomotor Development

Drugs mentioned

• Arachidonic acid supplement (arachidonic acid)

Snippet

Sponsor: Health Research Institute of Santiago | Conditions: Impaired Psychomotor Development | Phase 2 | Status: COMPLETED